Search

everythinglearnresearchcommunity

for

Search:↓

A 24-year-old woman had a rare ovarian tumor that caused male-pattern hair growth and was hard to diagnose and treat.

The patient has frontal fibrosing alopecia (FFA).

Fox Fordyce disease might be more common in prepubertal girls than thought and can be managed with treatment.

Alpha 6 + /MHCI - cells have stem cell traits and are similar to mouse hair follicle stem cells.

A woman's excessive hair growth and high testosterone were caused by a rare ovarian tumor, which was successfully treated with surgery.

Accurate diagnosis of NLS with dilated hair follicles is crucial to distinguish it from other conditions.

Fibrodysplasia ossificans progressiva is a rare genetic disorder that causes extra bone growth and symptoms of premature aging.

Recognizing and fully removing giant pilomatrixomas is crucial to prevent them from becoming cancerous.

MC-1R is present in skin cells and may help reduce inflammation.

Cutaneous keratocyst and steatocystoma should be called "sebaceous duct cyst" due to their similarities.

Combining anti-androgenic, anti-inflammatory, and anti-fibrotic treatments may improve hair loss outcomes, but more testing is needed.

The document suggests a possible link between frontal fibrosing alopecia and rosacea.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Targeting Hedgehog signaling may help treat ligamentum flavum fibrosis.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Myofibroblasts in rat wound healing may come from blood vessel pericytes and perifollicular dermal sheath cells.

Immunohistochemistry helps accurately identify and differentiate malignant trichilemmoma.

TURP specimens should be checked for various tumors, not just common prostate issues.

Frontal fibrosing alopecia in postmenopausal women can be managed with early treatment using corticosteroids to stop hair loss.

FFA patients have fewer melanocytes and thinner skin compared to others.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

Cyclosporine can cause a unique skin condition called "cyclosporine-induced folliculodystrophy."

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

An elderly woman's upper lip lump, thought to be a mucocele, was actually a rare type of lymphoma usually found on legs, treated successfully with chemotherapy and radiation.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Fibromodulin treatment helps reduce scarring and improves wound healing by making it more like fetal healing.

Dermal fibroblasts have at least three distinct types, each with unique roles in skin structure and hair development.